The application of Yunnan Baiyao combined with alcohol in the treatment of insulin-related subcutaneous fat hyperplasia based on ultrasound exploration

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083181

Enrollment

Unknown

Registered

2024-04-17

Start date

2024-04-20

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subcutaneous fat hyperplasia associated with insulin injections

Interventions

Observation group:Yunnan Baiyao combined with alcohol to improve the dressing

Control group:Normal nursing

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Be at least 18 years old, (2) meet the diagnostic criteria for T2DM [24] in the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes Mellitus (2020 Edition) and have been treated with pen insulin subcutaneous injection for more than 6 months, (3) At least one LH has been diagnosed by ultrasound exploration, (4) Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with acute of diabetes mellitus or severe cerebrovascular disease who cannot move independently, (2) Patients with severe skin diseases, severe scar tissue or allergies to research materials, (3) Patients with mental illness or cognitive impairment, (4) Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
Deep diameter of subcutaneous fat hyperplasia;	—

Secondary

Measure	Time frame
Long diameter of subcutaneous fat hyperplasia;Broad diameter of subcutaneous fat hyperplasia;blood sugar;	—

Countries

China

Contacts

Public ContactYaling Chen

Nanjing Jiangning Hospital

978502954@qq.com+86 135 8510 9701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026